During the past decade, Invicro, A Konica Minolta Company conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Invicro, A Konica Minolta Company" #1 collaborator was "Invicro" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Invicro, A Konica Minolta Company" are "Alzheimer Disease" (1 trials), "Alzheimer Disease (AD)" (1 trials), "Alzheimer's Disease" (1 trials) and "Healthy Volunteers" (1 trials). Many other conditions were trialed in "Invicro, A Konica Minolta Company" in a lesser frequency.

Most popular intervention types in "Invicro, A Konica Minolta Company" are "Drug" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "[18F]GTP1" (3 trials), "Placebo" (1 trials), "Semorinemab" (1 trials), "TAK-418" (1 trials) and "[18F]MK-6240" (1 trials). Other intervention names were less common.

The vast majority of trials in "Invicro, A Konica Minolta Company" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Invicro, A Konica Minolta Company". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Invicro, A Konica Minolta Company, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Invicro, A Konica Minolta Company, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".